Gabriela Mustata Wilson
Gabriela Mustata Wilson
Professor and Co-Director, University of Texas at Arlington
E-mail confirmado em
Citado por
Citado por
Discovery of novel Myc− Max heterodimer disruptors with a three-dimensional pharmacophore model
G Mustata, AV Follis, DI Hammoudeh, SJ Metallo, H Wang, ...
Journal of medicinal chemistry 52 (5), 1247-1250, 2009
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers
CL Dominguez, DH Floyd, A Xiao, GR Mullins, BA Kefas, W Xin, ...
Cancer discovery 3 (7), 782-797, 2013
Approaches to oral drug delivery for challenging molecules
G Mustata, SM Dinh
Critical Reviews™ in Therapeutic Drug Carrier Systems 23 (2), 2006
Discovery of modulators of protein-protein interactions: current approaches and limitations
L MC Meireles, G Mustata
Current topics in medicinal chemistry 11 (3), 248-257, 2011
Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen
ER Sharlow, D Close, T Shun, S Leimgruber, R Reed, G Mustata, P Wipf, ...
PLoS neglected tropical diseases 3 (11), e540, 2009
Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death
G Mustata, M Li, N Zevola, A Bakan, L Zhang, M Epperly, J S Greenberger, ...
Current topics in medicinal chemistry 11 (3), 281-290, 2011
A Target-Based High Throughput Screen Yields Trypanosoma brucei Hexokinase Small Molecule Inhibitors with Antiparasitic Activity
ER Sharlow, TA Lyda, HC Dodson, G Mustata, MT Morris, SS Leimgruber, ...
PLoS neglected tropical diseases 4 (4), e659, 2010
Comparative molecular dynamics simulations of HIV‐1 integrase and the T66I/M154I mutant: Binding modes and drug resistance to a diketo acid inhibitor
A Brigo, KW Lee, F Fogolari, GI Mustata, JM Briggs
PROTEINS: Structure, Function, and Bioinformatics 59 (4), 723-741, 2005
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors
GI Mustata, A Brigo, JM Briggs
Bioorganic & medicinal chemistry letters 14 (6), 1447-1454, 2004
Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain
A Brigo, KW Lee, GI Mustata, JM Briggs
Biophysical journal 88 (5), 3072-3082, 2005
Cluster analysis of water molecules in alanine racemase and their putative structural role
G Mustata, JM Briggs
Protein Engineering Design and Selection 17 (3), 223-234, 2004
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19)
Y Muftuoglu, G Mustata
Bioorganic & medicinal chemistry letters 20 (10), 3050-3064, 2010
The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation
CR Crossnoe, JP Germanas, P LeMagueres, G Mustata, KL Krause
Journal of molecular biology 318 (2), 503-518, 2002
HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines
PA Johnston, M Sen, Y Hua, DP Camarco, TY Shun, JS Lazo, GM Wilson, ...
Assay and drug development technologies 13 (7), 356-376, 2015
Molecular dynamics studies of alanine racemase: a structural model for drug design
GI Mustata, TA Soares, JM Briggs
Biopolymers: Original Research on Biomolecules 70 (2), 186-200, 2003
A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase
GI Mustata, JM Briggs
Journal of computer-aided molecular design 16 (12), 935-953, 2002
Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling
ER Delgado, J Yang, J So, M Fanti, S Leimgruber, M Kahn, T Ishitani, ...
The American journal of pathology 184 (7), 2111-2122, 2014
Development and implementation of a high-throughput high-content screening assay to identify inhibitors of androgen receptor nuclear localization in castration-resistant …
PA Johnston, MM Nguyen, JA Dar, J Ai, Y Wang, KZ Masoodi, T Shun, ...
Assay and drug development technologies 14 (4), 226-239, 2016
A novel benzodioxole-containing inhibitor of Toxoplasma gondii growth alters the parasite cell cycle
E Kamau, T Meehan, MD Lavine, G Arrizabalaga, G Mustata Wilson, ...
Antimicrobial agents and chemotherapy 55 (12), 5438-5451, 2011
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
J Zhao, L Zhang, X Mu, C Doebelin, W Nguyen, C Wallace, DP Reay, ...
PLoS biology 16 (6), e2004663, 2018
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20